Pulmonary tuberculosis treatment regimen recommended by the Brazilian National Ministry of Health: Predictors of treatment noncompliance in the city of Porto Alegre, Brazil;Fatores preditores para o abandono do tratamento da tuberculose pulmonar preconizado pelo Ministério da Saúde do Brasil na cidade de Porto Alegre (RS)

Jornal Brasileiro de Pneumologia

Volumn 37, Issue 6, 2011, Pages 776-782

  Campani, Simone Teresinha Aloise ^a   Moreira, José da Silva ^a   Tietbohel, Carlos Nunes ^b  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b Rio Grande do Sul State Health Department   (Brazil)

Author keywords

Medication adherence; Patient compliance; Patient dropouts; Primary health care; Tuberculosis

Indexed keywords

ADULT; AGE; ALCOHOLISM; BRAZIL; DEMOGRAPHY; EPIDEMIOLOGY; ETHNOLOGY; FEMALE; GOVERNMENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LUNG TUBERCULOSIS; MALE; PATIENT COMPLIANCE; PUBLIC HEALTH; REVIEW; RISK FACTOR; STATISTICS;

ADULT; AGE FACTORS; ALCOHOLISM; BRAZIL; EPIDEMIOLOGIC METHODS; FEMALE; GOVERNMENT AGENCIES; HIV INFECTIONS; HUMANS; MALE; NATIONAL HEALTH PROGRAMS; PATIENT COMPLIANCE; RESIDENCE CHARACTERISTICS; RISK FACTORS; TUBERCULOSIS, PULMONARY;

EID: 84855843131     PISSN: 18063713     EISSN: 18063756     Source Type: Journal    
DOI: 10.1590/S1806-37132011000600011     Document Type: Review

References (30)

1. Sociedade Brasileira de Pneumologia e Tisiologia. II Consenso Brasileiro de Tuberculose-Diretrizes Brasileiras para Tuberculose 2004. J Bras Pneumol. 2004;30(Suppl 1):S1-S56.
2. Lönnroth K, Raviglione M. Global epidemiology of tuberculosis: prospects for control. Semin Respir Crit Care Med. 2008;29(5):481-91.
3. Sumartojo E. When tuberculosis treatment fails. A social behavioral account of patient adherence. Am Rev Respir Dis. 1993;147(5):1311-20.
4. Vieira AA, Ribeiro SA. Noncompliance with tuberculosis treatment involving self administration of treatment or the directly observed therapy, short-course strategy in a tuberculosis control program in the city of Carapicuíba, Brazil. J Bras Pneumol. 2008;34(3):159-66.
5. Fundação Nacional de Saúde. Tuberculose: guia de vigilância epidemiológica. Brasília: Fundação Nacional de Saúde; 2002.
6. Boffo MM, Mattos IG, Ribeiro MO, Neto IC. Tuberculose associada à AIDS: características demográficas, clínicas e laboratoriais de pacientes atendidos em um serviço de referência em AIDS do sul do Brasil. J Pneumol. 2004;30(2):140-46.
7. Jamal LF, Moherdaui F. Tuberculosis and HIV infection in Brazil: magnitude of the problem and strategies for control [Article in Portuguese]. Rev Saude Publica. 2007;41 Suppl 1:104-10.
8. World Health Organization. Global Tuberculosis Control: Epidemiology, Strategy, Financing: WHO Report 2009. Geneva: World Health Organization; 2009.
9. Monroe AA, Gonzales RI, Palha PF, Sassaki CM, Ruffino Netto A, Vendramini SH, etal. Involvement of health primary care teams in the control of tuberculosis [Article in Portuguese]. Rev Esc Enferm USP. 2008;42(2):262-7.
10. Ott PW, Kwitko M, Soares IP, Guimarães M. Programa de Controle da Tuberculose no Rio Grande do Sul. In: Picon PD, Rizzon CF, Ott WP, edtors. Tuberculose: epidemiologia, diagnóstico e tratamento em clínica e saúde pública. Rio de Janeiro: Médica e Científica; 1993. p. 53-73.
11. Picon PD, Jarczewski CA, Unis G, Espina CA, Bassanesi SL, Ott WP. Fatores de Risco Para Não Adesão ao Tratamento da Tuberculose. J Bras Pneumol. 2006;32(Suppl 5):S265.
12. Picon PD, Rizzon CF, Freitas TM, Azevedo SN, Gutierrez RS. Resultados do tratamento. In: Picon PD, Rizzon CF, Ott WP, editors. Tuberculose: epidemiologia, diagnóstico e tratamento em clínica e saúde pública. Rio de Janeiro: Médica e Científica; 1993. p. 504-23.
13. World Health Organization. Group at risk: annual report, 1996. Geneva: WHO; 1996.
14. Pio A, Chaulet P. Tuberculosis Handbook. 2nd ed. Geneva: World Health Organization/HTM/TB; 2008.
15. Picon PD, Rizzon CF, Jarczewski CA. Fármacos Utilizados no Tratamento da Tuberculose. In: Barros E, Barros MM, editors. Medicamentos na Prática Clínica. São Paulo: ArtMed; 2010. p. 550-72.
16. Blumberg HM, Burman WJ, Chaisson RE, Daley CL, Etkind SC, Friedman LN, etal. American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis. Am J Respir Crit Care Med. 2003;167(4):603-62.
17. Tuberculosis Coalition for Technical Assistance. United States. International Standards for Tuberculosis Care: Diagnosis, Treatment, Public Health. Hague: Tuberculosis Coalition for Technical Assistance; 2006.
18. Menzies R, Rocher I, Vissandjee B. Factors associated with compliance in treatment of tuberculosis. Tuber Lung Dis. 1993;74(1):32-7. Erratum in: Tuber Lung Dis. 1993;74(3):217.
19. Natal S, Valente J, Gerhardt G, Penna ML. Modelo de predição para o abandono do tratamento da tuberculose pulmonar. Bol Pneumol Sanit. 1999;7(1):65-78.
20. Santos IS, Victora CG, Huttly S, Carvalhal JB. Caffeine intake and low birth weight: a population-based case-control study. Am J Epidemiol. 1998;147(7):620-7.
21. Bergel FS, Gouveia N. Frequent return as a novel strategy for tuberculosis treatment adherence [Article in Portuguese]. Rev Saude Publica. 2005;39(6):898-905.
22. Portal da Saúde. Sistema de Informação de Agravos de Notificação (SINAM) [homepage on the Internet] [cited 2011 Apr 26]. Brasília: Ministério da Saúde. Available from: http://dtr2004.saude.gov.br/sinanweb/
23. Deheinzelin D, Takagaki TY, Sartori AM, Leite OH, Amato Neto V, Carvalho CR. Fatores preditivos de abandono de tratamento por pacientes com tuberculose. Rev Hosp Clin Fac Med Univ Säo Paulo. 1996;51(4):131-5.
24. Burman WJ, Cohn DL, Rietmeijer CA, Judson FN, Sbarbaro JA, Reves RR. Noncompliance with directly observed therapy for tuberculosis. Epidemiology and effect on the outcome of treatment. Chest. 1997;111(5):1168-73.
25. Mendes AM, Fensterseifer LM. Tuberculose: porque os pacientes abandonam o tratamento? Bol Pneumol Sanit. 2004;12(1):25-36.
26. Costa JS, Gonçalves H, Menezes AM, Devens E, Piva M, Gomes M. Controle epidemiológico da tuberculose na cidade de Pelotas, Rio Grande do Sul, Brasil: adesão ao tratamento. Cad. Saude Publica. 1998;14(2):409-15.
27. Muniz JN, Ruffino-Netto A, Villa TC, Yamamura M, Arcencio R, Cardozo-Gonzales RI. Epidemiological aspects of human immunodeficiency virus/tuberculosis co-infection in Ribeirão Preto, Brazil from 1998 to 2003 J Bras Pneumol. 2006;32(6):529-34.
28. Paixão LM, Gontijo ED, Perfil de casos de tuberculose notificados e fatores associados ao abandono, Belo Horizonte, MG. Rev Saude Publica. 2007;41(2):205-13.
29. Ferreira SM, Silva AM, Botelho C. Noncompliance with treatment for pulmonary tuberculosis in Cuiabá, in the state of Mato Grosso. J Bras Pneumol. 2005;31(5):427-35.
30. Ribeiro AS, Amado VM, Camelier AA, Marcia MA, Fernandes MM, Schenkman S. Estudo caso-controle de indicadores de abandono em doentes com tuberculose. J Pneumol. 2000;26(6):291-6.